Establishing bioequivalence is difficult for drugs with high inter-subject variability or strong dependence on the physiological state of the gut.
Nasir M. Idkaidek, Ph.D.
Advertisement
Articles by Nasir M. Idkaidek, Ph.D.
Advertisement
Latest Updated Articles
Gastric-State-Controlled Bioequivalence StudiesPublished: October 1st 2004 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
How Enzymatic Platforms May Change the Therapeutic RNA Supply Chain
2
How Is AI Transforming Biomanufacturing and Biopharma Workforce Training?
3
BioPharma By the Numbers: Bioprocess Hiring Creating Capacity Constraints
4
Q&A: Strategies for Supply Chain Resilience and Next-Generation Process Optimization
5
